These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3753024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [Abstract] [Full Text] [Related]

  • 4. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 5. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K, Nagahama F, Nakai Y, Nakabayashi T, Hiraga Y, Takebe K, Tamura M, Oizumi K, Sato M, Ito T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K, Yamada K, Yoshida T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [Abstract] [Full Text] [Related]

  • 9. [Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].
    Niijima T, Tazaki H.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2305-11. PubMed ID: 3044277
    [Abstract] [Full Text] [Related]

  • 10. [Phase II study of VP-16 (capsule) in solid tumors. A cooperative study].
    Honma T, Ogawa M, Yoshida S, Meguro S, Hirano M, Hoshino A, Shirakawa S, Nakamura T, Fukuoka M, Toki H.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):309-13. PubMed ID: 2982332
    [Abstract] [Full Text] [Related]

  • 11. [Effect of etoposide for urogenital tumors].
    Kinjo T, Murase T, Aota Y, Shimoji T, Mitsuya H.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1267-71. PubMed ID: 4004290
    [Abstract] [Full Text] [Related]

  • 12. [Phase I study of an oral administration of VP 16-213].
    Ogawa M, Ota K, Oyama A, Fukuoka M, Takada M, Yoshida S, Sanpi K, Kimura I, Ohnoshi T, Kuraishi Y.
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
    [Abstract] [Full Text] [Related]

  • 13. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I, Kitani T, Nagai K, Kanamaru A, Kohsaki M, Masaoka T, Shibata H, Horiuchi A, Tsubaki K, Kawagoe H.
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
    [Abstract] [Full Text] [Related]

  • 14. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Yoshida T, Nakanishi J, Ito K, Kobayashi S, Ohtake S, Nakamura S, Hattori K.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
    [Abstract] [Full Text] [Related]

  • 15. Oral VP-16-213 in transitional cell carcinoma of the bladder: a phase II study.
    Panduro J, Hansen M, Hansen HH.
    Cancer Treat Rep; 1981 Aug; 65(7-8):703-4. PubMed ID: 7248987
    [No Abstract] [Full Text] [Related]

  • 16. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
    Furuse K.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
    [Abstract] [Full Text] [Related]

  • 17. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
    [Abstract] [Full Text] [Related]

  • 18. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T, Kasai Y, Wakui A, Furue H, Majima H, Nitani H, Niijima T, Takeda C, Abe O, Koyama Y.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [Abstract] [Full Text] [Related]

  • 19. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
    Wakui A, Yokoyama M, Takahashi H, Yoshida Y, Sakata Y, Sato S, Kano A, Kawamoto K, Hashimoto S, Konno K.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
    [Abstract] [Full Text] [Related]

  • 20. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
    Niijima T, Koyanagi T, Maru A, Sakashita S, Koiso K, Ishikawa H, Uchida K, Shimazaki J, Isaka S, Akaza H.
    Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.